NewsRoom Articles - Page 574 of 591

MondayJun 26, 2017 2:52 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targeting Blockbuster Therapeutics

The medical efficacy of cannabinoids to treat a multiplicity of maladies is no longer in doubt. Two recently published scientific studies dispelled any apprehensions about cannabis-based therapies. The highly respected New England Journal of Medicine published a peer reviewed article that proved in a controlled study that cannabidiol dramatically reduced the number of convulsive seizures in children stricken with a severe epileptic disorder (http://nnw.fm/i0X0D). The results of this study follow a comprehensive report by the National Academies of Science, Engineering, and Medicine which confirmed that cannabinoids are effective at treating chronic pain and for providing relief from nausea and vomiting…

MondayJun 26, 2017 8:54 am

SinglePoint’s (SING) $1M Promissory Note Furthers Efforts to Offer Bitcoin Payment Solution for Cannabis Businesses

Furthering its efforts to innovate solutions for the cannabis industry, SinglePoint, Inc. (OTC: SING) has taken a step forward in its endeavor to offer a bitcoin payments solution for cannabis businesses through its partnership with First Bitcoin Capital Corp. (OTC: BITCF). SinglePoint recently announced (http://nnw.fm/dS8l3) it has successfully closed a $1 million convertible promissory note with an institutional investor — the proceeds from which will be used to fund the company’s bitcoin payments endeavor and will enable SinglePoint to move quickly in developing a cryptocurrency solution and continuing its acquisitions activities in the cannabis space. A lack of banking options…

ThursdayJun 22, 2017 3:41 pm

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) Takes Additional Step toward Clinical Trials for INM-750

Moving toward offering the very first therapy for treating epidermolysis bullosa (EB), InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) recently announced it has signed an agreement with Pharmaseed Ltd. (http://nnw.fm/4lZzC) to develop a final formulation for INM-750, InMed’s lead compound, which is being developed as a therapy for EB and for other potential dermatological and wound-healing applications. EB is a group of inherited connective tissue diseases sharing a common manifestation of very fragile skin that is prone to easily blistering or tearing. An orphan disease that currently has no approved treatments and has significant unmet medical need, EB results from…

ThursdayJun 22, 2017 3:24 pm

ChineseInvestors.com, Inc. (CIIX) Raises Profile, Increases Revenues from Investor Relations Activity

ChineseInvestors.com, Inc. (OTCQB: CIIX) has been closely monitored for its upside as it competes in the hemp-derived cannabis market. CIIX has launched a cannabidiol (CBD) online store in the free-trade zone of Shanghai and soon it plans to open a brick-and-mortar store in its home market of San Gabriel, California, to market a line of food and nutrition products. However, the bulk of its existing business remains in investor relations, which is growing as the company invests more in personnel and advertising, successfully raising its profile. CIIX offers a variety of consulting services to Chinese-speaking clients and companies. It offers…

ThursdayJun 22, 2017 9:00 am

Diverse Opportunities Aplenty for Investors Interested in the Marijuana Market

CannabisNewsWire Editorial Coverage: Within the exploding legalized marijuana industry, new innovations and investment opportunities are cropping up all the time; no matter what sector you have interest in, there is likely an investment option to be explored. Among enterprising companies looking for innovative ways to profit within the blossoming marijuana market, SinglePoint, Inc. (SING) (SING Profile), First Bitcoin Capital Corp. (BITCF), Kush Bottles, Inc. (KSHB), Medical Marijuana, Inc. (MJNA) and Solis Tek, Inc. (SLTK) offer diverse opportunities for savvy investors interested in a marijuana-related play. The growth of the legal marijuana market has been bigger and faster than the growth…

WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

TuesdayJun 20, 2017 3:53 pm

InMed Pharmaceuticals, Inc. (IMLFF) is a Player in the Billion Dollar Cannabis Biotech Market

Despite the fire-breathing from Attorney-General Jefferson Beauregard Sessions III, there is a distinct feeling that marijuana has entered the mainstream now that Goldman Sachs has initiated coverage on GW Pharma (NASDAQ: GWPH). GW Pharma is the biopharmaceutical that developed the cannabinoid-derived Sativex to treat spasticity due to multiple sclerosis (MS), now approved by regulatory authorities in 29 countries. The success of GW Pharma and other pharmaceutical companies focused on cannabinoid research has produced an exciting new field with a lot of promise, cannabis biotech, and InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is staking a position in that emerging market.…

MondayJun 19, 2017 2:41 pm

InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team. Insider Financial highlighted InMed Pharmaceuticals as a “Cannabis Runner” in an article back in January, stating that “This is the kind of company that needs to maintain a positive news flow in order to keep investors interested.” More recently, Forbes released an article describing the company as “more than just another cannabis drug…

ThursdayJun 15, 2017 4:30 pm

PotNetwork Holdings, Inc. (POTN) Starts Presentation at the 2017 Marcum Microcap Conference

PotNetwork Holdings (OTC: POTN) acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc. Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. For more information, visit the company's website at www.potnetworkholding.com About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full array of social communication solutions. As a multifaceted financial news and content distribution company…

ThursdayJun 15, 2017 4:30 pm

Therapix Biosciences Ltd. (NASDAQ: TRPX) Starts Presentation at the 2017 Marcum Microcap Conference

Therapix Biosciences (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company is currently engaged in two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): THX-TS01 targets to the treatment of Tourette's syndrome; and THX-ULD01 targets the high-value and under-served market of mild cognitive impairments. For more information, visit the company's website at www.therapixbio.com About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides to users (1) access to our…

News and publishing service for cannabis related companies

Contact us: 512.354.7000